Outcomes With Treatment and Withdraw of Secukinumab in Patients With Plaque Psoriasis

Condition:   Plaque Psoriasis Interventions:   Biological: secukinumab;   Drug: Methotrexate;   Drug: Cyclosporin A;   Drug: Acitretin Sponsors:   Singapore General Hospital;   Translational Immunology Institute Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials